1. Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. (12th April 2018) Authors: White, William B.; Chapple, Christopher; Gratzke, Christian; Herschorn, Sender; Robinson, Dudley; Frankel, Jeffrey; Ridder, Arwin; Stoelzel, Matthias; Paireddy, Asha; van Maanen, Robert; Weber, Michael A. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 8(2018) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nominal GDP targeting for developing countries. Issue 3 (September 2017) Authors: Bhandari, Pranjul; Frankel, Jeffrey Journal: Research in economics Issue: Volume 71:Issue 3(2017) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD38-11 LONG-TERM EFFICACY AND SAFETY OF VIBEGRON FOR OVERACTIVE BLADDER IN PATIENTS ≥65 YEARS OLD: ANALYSIS FROM THE EMPOWUR EXTENSION TRIAL. (May 2022) Authors: Frankel, Jeffrey; Varano, Susann; Greene, Heather; Thomas, Elizabeth; Staskin, David Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e649 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PD38-12 LONG-TERM PATIENT-REPORTED OUTCOMES OF VIBEGRON FOR OVERACTIVE BLADDER: ANALYSES FROM THE EMPOWUR EXTENSION TRIAL. (May 2022) Authors: Staskin, David; Varano, Susann; Greene, Heather; Thomas, Elizabeth; Frankel, Jeffrey Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e650 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial. (13th April 2022) Authors: Staskin, David; Frankel, Jeffrey; Varano, Susann; Kennelly, Michael; Newman, Diane K.; Rosenberg, Matt T.; Shortino, Denise D.; Jankowich, Rachael A.; Mudd Jr, Paul N. Other Names: Wang Qing Academic Editor. Journal: International journal of clinical practice Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study. Issue 5 (22nd January 2021) Authors: Frankel, Jeffrey; Varano, Susann; Staskin, David; Shortino, Denise; Jankowich, Rachael; Mudd, Paul N. Journal: International journal of clinical practice Issue: Volume 75:Issue 5(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗